======= WNT9A ======= == Gene Information == * **Official Symbol**: WNT9A * **Official Name**: Wnt family member 9A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7483|7483]] * **UniProt**: [[https://www.uniprot.org/uniprot/O14904|O14904]] * **Interactions**: [[https://thebiogrid.org/search.php?search=WNT9A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20WNT9A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602863|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Ligand for members of the frizzled family of seven transmembrane receptors. Functions in the canonical Wnt/beta- catenin signaling pathway. Required for normal timing of IHH expression during embryonic bone development, normal chondrocyte maturation and for normal bone mineralization during embryonic bone development. Plays a redundant role in maintaining joint integrity. {ECO:0000250|UniProtKB:O42280, ECO:0000250|UniProtKB:Q8R5M2}. |wnt| |cornea development in camera-type eye| |iris morphogenesis| |embryonic skeletal joint development| |negative regulation of chondrocyte differentiation| |negative regulation of cartilage development| |positive regulation of smoothened signaling pathway| |receptor ligand activity| |embryonic forelimb morphogenesis| |frizzled binding| |forelimb morphogenesis| |regulation of chondrocyte differentiation| |cellular response to retinoic acid| |regulation of cartilage development| |regulation of smoothened signaling pathway| |negative regulation of cysteine-type endopeptidase activity involved in apoptotic process| |canonical Wnt signaling pathway| |negative regulation of cysteine-type endopeptidase activity| |embryonic skeletal system morphogenesis| |response to retinoic acid| |camera-type eye morphogenesis| |embryonic limb morphogenesis| |embryonic appendage morphogenesis| |embryonic skeletal system development| |eye morphogenesis| |limb morphogenesis| |appendage morphogenesis| |mitotic cell cycle checkpoint| |appendage development| |limb development| |cell cycle checkpoint| |cellular response to acid chemical| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |skeletal system morphogenesis| |regulation of cysteine-type endopeptidase activity| |negative regulation of endopeptidase activity| |cell fate commitment| |negative regulation of peptidase activity| |sensory organ morphogenesis| |embryonic organ morphogenesis| |negative regulation of mitotic cell cycle| |camera-type eye development| |response to acid chemical| |negative regulation of proteolysis| |Wnt signaling pathway| |cell-cell signaling by wnt| |eye development| |visual system development| |sensory system development| |regulation of endopeptidase activity| |cell surface receptor signaling pathway involved in cell-cell signaling| |embryonic organ development| |regulation of peptidase activity| |negative regulation of hydrolase activity| |skeletal system development| |cellular response to lipid| |sensory organ development| |embryonic morphogenesis| |negative regulation of cell cycle| |mitotic cell cycle process| |regulation of mitotic cell cycle| |chordate embryonic development| |embryo development ending in birth or egg hatching| |negative regulation of cell population proliferation| |mitotic cell cycle| |negative regulation of cell differentiation| |regulation of proteolysis| |negative regulation of catalytic activity| |response to lipid| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |negative regulation of developmental process| |animal organ morphogenesis| |positive regulation of cell differentiation| |embryo development| |negative regulation of cell death| |cell cycle process| |neuron differentiation| |negative regulation of cellular protein metabolic process| |cellular response to oxygen-containing compound| |negative regulation of protein metabolic process| |cell-cell signaling| |negative regulation of molecular function| |regulation of cell cycle| |negative regulation of multicellular organismal process| |regulation of hydrolase activity| |cell cycle| |positive regulation of developmental process| |generation of neurons| |regulation of apoptotic process| |response to oxygen-containing compound| |regulation of programmed cell death| |extracellular space| |regulation of cell population proliferation| |neurogenesis| |positive regulation of signal transduction| |regulation of cell death| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp271|CCT251545 0.2μM R06 exp271]]|1.88| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12845 * **Expression level (log2 read counts)**: -1.13 {{:chemogenomics:nalm6 dist.png?nolink |}}